Stammdaten
Stemtech Corporation, a stem cell nutrition company, develops science-based products to help the body maintain healthy stem cell physiology in the Americas, Latin America, and Asia. The company's products enhance and support the work of the body's stem cells by releasing more stem cells, helping to circulate them in the blood, and migrate them into tissues, where they can perform their daily function of renewal for optimal health. It offers its dietary supplement products under the RCM System, stemrelease3, Stemflo MigraStem, DermaStem, DermaStem Lift, OraStem, and D-Fuze brands. The company is based in Miramar, Florida.
Unternehmen & Branche
| Name | Stemtech Corp |
|---|---|
| Ticker | STEK |
| CIK | 0001511820 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Drug Manufacturers - Specialty & Generic |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 29.235 USD |
| Beta | 2,37 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | 852,300 | -809,406 | -0.01 | 3,755,801 | -5,800,215 |
| 2025-06-30 | 10-Q | 697,925 | -293,145 | 0.00 | 3,872,156 | -5,705,944 |
| 2025-03-31 | 10-Q | 868,046 | -1,455,591 | -0.01 | 3,754,250 | -4,937,407 |
| 2024-12-31 | 10-Q | -3,769,566 | 3,782,245 | -4,484,176 | ||
| 2024-12-31 | 10-K | 5,053,690 | -3,769,566 | -0.03 | 3,782,245 | -4,484,176 |
| 2024-09-30 | 10-Q | 1,031,630 | -1,170,480 | -0.01 | ||
| 2024-06-30 | 10-Q | 1,325,800 | -784,156 | -0.01 | 3,690,246 | -4,186,747 |
| 2024-03-31 | 10-Q | 1,382,570 | -1,418,350 | -0.02 | 3,612,053 | -3,704,117 |
| 2023-12-31 | 10-Q | -5,430,245 | 3,683,271 | -2,039,272 | ||
| 2023-12-31 | 10-K | 4,921,531 | -5,430,245 | -0.07 | 3,683,271 | -2,039,272 |
| 2023-09-30 | 10-Q | 1,298,322 | -1,041,800 | -0.01 | 4,149,022 | -956,834 |
| 2023-06-30 | 10-Q | 1,128,126 | -286,919 | 0.00 | 4,402,213 | -568,037 |
| 2023-03-31 | 10-Q | 1,133,341 | -2,236,730 | -0.04 | 4,557,003 | -3,975,147 |
| 2022-12-31 | 10-K | 4,559,399 | -8,544,923 | -0.19 | 4,266,941 | -2,434,159 |
| 2022-09-30 | 10-Q | 1,047,030 | 17,416,917 | 0.38 | 4,350,695 | -4,001,048 |
| 2022-06-30 | 10-Q | 1,276,424 | -24,948,239 | -0.56 | 4,718,916 | -28,088,141 |
| 2022-03-31 | 10-Q | 1,156,308 | -494,740 | -0.01 | 5,128,536 | -3,947,325 |
| 2021-12-31 | 10-K | 4,321,245 | -7,077,463 | -0.20 | 5,720,122 | -3,355,592 |
| 2021-09-30 | 10-Q | 907,854 | -5,309,390 | -0.28 | 6,276,435 | -4,432,835 |
| 2021-06-30 | 10-Q | 1,025,112 | -762,565 | -0.02 | -247,927 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.